Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Overcoming Oligonucleotide Manufacturing Challenges - Polypeptide

Overcoming Oligonucleotide Manufacturing Challenges The Oligonucleotide CMO industry faces a number of challenges – Demand out pacing capacity for manufacturing, available expertise, high solvent and waste usage to name a few. The PolyPeptide Group established

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Overcoming Oligonucleotide Manufacturing Challenges

The Oligonucleotide CMO industry faces a number of challenges – Demand out pacing capacity for manufacturing, available expertise, high solvent and waste usage to name a few. The PolyPeptide Group established its OLIGO@POLYPEPTIDE division to help address some of these challenges and bring much needed medicine to patients. We discuss how PolyPeptide has leveraged its expertise in peptide manufacturing to address these challenges.

Presented at TIDES ASIA, March 8, 2023 by Loïc Cornelissen, Ph. D., Sales Manager at PolyPeptide.

Related posts

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →